FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical industry and ophthalmosurgery and is a vital dye for contrasting the intraocular structures of the posterior segment of the eye, containing Trypan blue, sodium chloride, distilled water in solution, BBG dye, disodium phosphate, sodium dihydrogen phosphate, polyethylene glycol (PEG) and sodium hyaluronate, and the components of the solution are in a certain ratio of 1 ml of solution.
EFFECT: invention provides increased safety of the vital solution, which has pro- and antioxidant activity, due to the enhancement of biological inertness.
1 cl, 24 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EXAMINING RETINAL SURFACE IN ENDOVITREAL SURGERY | 2020 |
|
RU2742758C1 |
| METHOD FOR SURGICAL TREATMENT OF REGMATOGENIC RETINAL DETACHMENT COMPLICATED BY RETINAL TEARS | 2020 |
|
RU2754514C1 |
| METHOD FOR SURGICAL TREATMENT OF MACULAR HOLE WITH TARGETED PRESERVATION OF FOVEAL INNER LIMITING MEMBRANE IN THE AREA OF FIXATION POINT | 2022 |
|
RU2794859C1 |
| METHOD FOR SURGICAL TREATMENT OF WET MACULAR DEGENERATION COMPLICATED BY SECONDARY EPIRETINAL MEMBRANE | 2021 |
|
RU2758026C1 |
| METHOD OF RAPID ASSESSMENT OF THE VITAL DYE FOR CONTRASTING INTRAOCULAR STRUCTURES OF THE POSTERIOR SEGMENT OF THE EYE | 2017 |
|
RU2669945C1 |
| METHOD FOR DETACHING POSTERIOR BOUNDARY MEMBRANE | 2002 |
|
RU2222297C2 |
| METHOD FOR SURGICAL TREATMENT OF MACULAR RUPTURE WHILE PRESERVING FOVEAL INNER BORDER MEMBRANE | 2021 |
|
RU2754513C1 |
| METHOD OF SURGICAL SERVICE OF THE IDIOPATHIC EPIRETHINAL MEMBRANE | 2017 |
|
RU2644296C1 |
| METHOD OF SIMULATING RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2727000C1 |
| METHOD FOR SURGICAL MANAGEMENT OF MACULAR RUPTURES WITH PRESERVATION OF INTERNAL LIMITING MEMBRANE | 2023 |
|
RU2821653C1 |
